1. B. Samuelsson, Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation, Science, 220:568–575, (1983).
2. B. Samuelsson, S.-E. Dahlén, J.-Å. Lindgren, C.A. Rouzer, and C.N. Serhan, Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects, Science, 237:1171–1176, (1987).
3. S.-E. Dahlén, G. Hansson, P. Hedqvist, T. Björck, E. Granström, and B. Dahlén, Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4 and E4, Proc. Natl. Acad. Sci. USA, 80:1712–1716,(1983).
4. R.A. Coleman, R.M. Eglen, R.L. Jones, S. Narumiya, T. Shimizu, W.L. Smith, S.E. Dahlén, J.M. Drazen, P.J. Gardiner, W.T. Jackson, T.R. Jones, R.D. Krell, and S. Nicosia, Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature, in: Adv. Prostaglandin Thromboxane Leukotriene Res, 23:283–285, (1995).
5. P.R. Devchand, H. Keller, J.M. Peters, M. Vazquez, F.J. Gonzalez, and W. Wahli, The ppar-alpha-leukotriene b-4 pathway to inflammation control, Nature, 384:39–43, 1996.